Abattis Announces New Board Members (PR)

0 Responses Abattis News

Vancouver, British Columbia / Newsfile Corp. / June 7, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the “Company” or “Abattis“) is pleased to announce the appointment of Robert Abenante and Peter Gordon to its Board of Directors. Mr. Abenante is the President and CEO of Abattis and its subsidiaries. He is a seasoned executive […]